The Valley Desk

NCT01042379 · Interventional trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Overall registry status Recruiting

Phase 2

Conditions Angiosarcoma, Breast Cancer, Breast Neoplasms, Breast Tumors, Early-stage Breast Cancer, HER2-negative Breast Cancer, HER2-positive Breast Cancer, Hormone Receptor Negative Tumor, Hormone Receptor Positive Tumor, Locally Advanced Breast Cancer, TNBC - Triple-Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov